Strober B - Search Results

1

Anti-interleukin-17 treatment of psoriasis.

Jinna S, Strober B. Jinna S, et al. Among authors: strober b. J Dermatolog Treat. 2016 Aug;27(4):311-5. doi: 10.3109/09546634.2015.1115816. Epub 2016 Mar 4. J Dermatolog Treat. 2016. PMID: 26943806 Review.

2

The potential of interleukin 12 inhibition in the treatment of psoriasis.

Rosmarin D, Strober BE. Rosmarin D, et al. J Drugs Dermatol. 2005 May-Jun;4(3):318-25. J Drugs Dermatol. 2005. PMID: 15898287 Review.

3

The treatment of psoriasis with etanercept.

Strober BE. Strober BE. Semin Cutan Med Surg. 2005 Mar;24(1):28-36. doi: 10.1016/j.sder.2005.01.003. Semin Cutan Med Surg. 2005. PMID: 15900796 Review.

4

Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.

Menon K, Van Voorhees AS, Bebo BF Jr, Gladman DD, Hsu S, Kalb RE, Lebwohl MG, Strober BE; National Psoriasis Foundation. Menon K, et al. J Am Acad Dermatol. 2010 Feb;62(2):291-9. doi: 10.1016/j.jaad.2009.03.047. Epub 2009 Jul 31. J Am Acad Dermatol. 2010. PMID: 19646777 Review.

5

Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis.

Langley RG, Strober BE, Gu Y, Rozzo SJ, Okun MM. Langley RG, et al. Among authors: strober be. Br J Dermatol. 2010 Jun;162(6):1349-58. doi: 10.1111/j.1365-2133.2010.09707.x. Epub 2010 Apr 14. Br J Dermatol. 2010. PMID: 20394634 Review.

6

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis.

Strober BE, Crowley JJ, Yamauchi PS, Olds M, Williams DA. Strober BE, et al. Br J Dermatol. 2011 Sep;165(3):661-8. doi: 10.1111/j.1365-2133.2011.10419.x. Epub 2011 Jul 28. Br J Dermatol. 2011. PMID: 21574984 Clinical Trial.

7

The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials.

Leonardi C, Papp K, Strober B, Reich K, Asahina A, Gu Y, Beason J, Rozzo S, Tyring S. Leonardi C, et al. Among authors: strober b. Am J Clin Dermatol. 2011 Oct 1;12(5):321-37. doi: 10.2165/11587890-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21834597 Review.

8

Biopharmaceuticals and biosimilars in psoriasis: what the dermatologist needs to know.

Strober BE, Armour K, Romiti R, Smith C, Tebbey PW, Menter A, Leonardi C. Strober BE, et al. J Am Acad Dermatol. 2012 Feb;66(2):317-22. doi: 10.1016/j.jaad.2011.08.034. J Am Acad Dermatol. 2012. PMID: 22243723 Review.

9

Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial.

Strober BE, Sobell JM, Duffin KC, Bao Y, Guérin A, Yang H, Goldblum O, Okun MM, Mulani PM. Strober BE, et al. Br J Dermatol. 2012 Dec;167(6):1374-81. doi: 10.1111/bjd.12000. Epub 2012 Nov 2. Br J Dermatol. 2012. PMID: 22897348 Clinical Trial.

10

Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis.

Langley RG, Papp K, Gottlieb AB, Krueger GG, Gordon KB, Williams D, Valdes J, Setze C, Strober B. Langley RG, et al. Among authors: strober b. J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1252-61. doi: 10.1111/j.1468-3083.2012.04705.x. Epub 2012 Nov 16. J Eur Acad Dermatol Venereol. 2013. PMID: 23157612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page